AKT1 and lung cancer: Luteolin treatment also reduced the PM2.5-activated epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) signaling transduction in human H460 lung cancer cells.